HKSecWiki新股資訊 2022年10月27日
10:20 PM EDT, 10/26/2022 (MT Newswires) -- LEPU ScienTech Medical Technology (Shanghai) (HKG:2291) launched its initial public offering in Hong Kong Thursday, seeking to raise up to HK$706.2 million ($90 million) from the deal.
美國東部時間2022年10月26日晚10：20(MT Newwires)--樂普科創醫療科技(上海)(HKG：2291)周四在香港進行首次公開募股，尋求通過這筆交易籌集至多7.062億港元(合9000萬美元)。
The medical device manufacturer is offering up to 22,455,000 shares, expected to be priced in the range of HK$29.15 to HK$31.45 per share, according to a same-day filing.
根據同日提交的一份文件，這傢醫療器械制造商將發行至多22,455,000股票，預計發行價在每股29.15港元至31.45港元之間。
The company expects to determine the price of the IPO on Nov. 1 and disclose the results of the allocation on Nov. 7. The shares will begin trading on the stock exchange on Nov. 8.
該公司預計將於11月1日確定IPO價格，並於11月7日公佈分配結果。股票將於11月8日開始在證券交易所交易。
The medical device manufacturer intends to use the proceeds for research and development within the next five years. The proceeds will also be used for the recruitment of personnel, sales and marketing activities, investments and acquisitions, expansion of production capacity, and for working capital and general corporate purposes.
這傢醫療器械制造商打算在未來五年內將所得資金用於研發。所得款項還將用於招聘人員、銷售和營銷活動、投資和收購、擴大產能，以及用於營運資金和一般企業用途。
LEPU ScienTech Medical Technology attracted Harvest Great Bay Investment, Shanghai Lingang Economic Development Group Investment Management, and Jointown International Group as cornerstone investors.
樂普科創醫療科技吸引瞭嘉實大灣投資、上海臨港經濟發展集團投資管理、聯城國際集團作為基石投資者。
China International Capital Corporation, CLSA, China Galaxy, Huatai Financial Holdings, and Valuable Capital are the joint bookrunners and lead managers of the IPO.
中金公司、裡昂證券、中國銀河、華泰證券金控和寶貴資本為此次IPO的聯席賬簿管理人和牽頭經辦人。
本頁的譯文內容由軟件翻譯。富途將竭力但卻不能保證翻譯內容之準確和可靠，亦不會承擔因任何不準確或遺漏而引起的任何損失或損害。
Was this helpful?
0 / 0
本文链接： https://hk.hksecwiki.com/news/hkp20785552/
由HKSecWiki香港券商百科整理发布，香港证券开户请访问hksecwiki.com